Table 1 Interview responses part 1
|  | Thailand hospital tender (n = 4) | Indonesia hospital drug purchasing (n = 4) |
|---|---|---|
Rationale for using MCDA | Improve quality at reasonable cost Achieve transparency with agreed criteria Consistency across hospitals | Listing only the best (most effective and affordable) alternatives Rational selection process Decisions meet hospital needs |
Opportunities: expected differences due to MCDA (number of mentions) | Better patient health [3] Transparency [2] Better accuracy/consistency in scoring [2] Better acceptance of purchasing decision by HCP and patients [2] Quality improvement [1] More fairness in tender [1] Change in hospital purchasing practices [1] Better product performance [1] Awareness [1] Better guidance of companies what type of products are expected [1] Better access for high-quality products [1] | Quality of products [4] Affordability [2] More objective/rational decision [2] Transparency in tender or formulary selection [2] Fairness in Off-Patent-Pharmaceutical market [1] Better decisions on the formulary [1] Better (monitoring of) availability [1] More (objective) consideration of value-added services [1] |